The Enteric Nervous System and Its Emerging Role as a Therapeutic Target
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The gastrointestinal (GI) tract is innervated by the enteric nervous system (ENS), an extensive neuronal network that traverses along its walls. Due to local reflex circuits, the ENS is capable of functioning with and without input from the central nervous system. The functions of the ENS range from the propulsion of food to nutrient handling, blood flow regulation, and immunological defense. Records of it first being studied emerged in the early 19 th century when the submucosal and myenteric plexuses were discovered. This was followed by extensive research and further delineation of its development, anatomy, and function during the next two centuries. The morbidity and mortality associated with the underdevelopment, infection, or inflammation of the ENS highlight its importance and the need for us to completely understand its normal function. This review will provide a general overview of the ENS to date and connect specific GI diseases including short bowel syndrome with neuronal pathophysiology and current therapies. Exciting opportunities in which the ENS could be used as a therapeutic target for common GI diseases will also be highlighted, as the further unlocking of such mechanisms could open the door to more therapy-related advances and ultimately change our treatment approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · cited 1×
“Glucagon-like peptide 2 (GLP-2) is heavily involved in the digestive process and is cosecreted, along with its sister hormone GLP-1, from enteroendocrine L-cells of the small and large intestines [68, 154].”
BackgroundThe enteric nervous system and neurogastroenterology
Furness, J. B. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.32 · Cited by 1,619 · cited 3×
“The primary neurotransmitters of IPANs are acetylcholine, calcitonin gene-related peptide (CGRP), and tachykinin; the secondary neurotransmitter is undetermined [4, 9, 41].”
BackgroundT1R3 and gustducin in gut sense sugars to regulate expression of Na + -glucose cotransporter 1
Margolskee, R. F., Dyer, J., Kokrashvili, Z., Salmon, K. S. H., Ilegems, E., Daly, K., Maillet, E. L., Ninomiya, Y., Mosinger, B., & Shirazi-Beechey, S. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706678104 · Cited by 882 · cited 1×
“There is evidence to suggest that these cells detect and participate in the transport of glucose across the mucosa via the activation of glucose transporters by GLP-2 [100].”
BackgroundTypes of neurons in the enteric nervous system
Furness, J. B. (2000) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(00)00127-2 · Cited by 855 · cited 8×
“It is easy to understand how the secretomotor and vasomotor neurons work in tandem to regulate epithelial secretion and blood flow, and it is important to note that these reflexes are under extrinsic modulation via the sympathetics [9].”
BackgroundInfluentialThe enteric nervous system and gastrointestinal innervation: integrated local and central control
Furness, J. B., Callaghan, B. P., Rivera, L. R., & Cho, H.-J. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_3 · Cited by 827
Schmulson, M. J., & Drossman, D. A. (2017) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm16214 · Cited by 788 · cited 1×
“IBS is typically diagnosed using the Rome IV criteria—a 3-month history of recurrent abdominal pain for at least 1 day per week in addition to experiencing two or more symptoms such as defecation, change in stool frequency, or change in stool form [148, 151].”
MethodEndocrine cells in human intestine: an immunocytochemical study
Sjölund, K., Sandén, G., Håkanson, R., & Sundler, F. (1983) · Gastroenterology · doi:10.1016/s0016-5085(83)80080-8 · Cited by 520 · cited 1×
“The major transmitters include, but are not limited to, cholecystokinin (CCK), secretin, somatostatin, serotonin (5-HT), corticotrophin-releasing factor, gastrin, leptin, ghrelin, and glucagon-like peptide 2 (GLP-2) [11, 15, 99].”
BackgroundCollins, S. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70034-3 · Cited by 511
Jeppesen, P. B., Pertkiewicz, M., Messing, B., Iyer, K., Seidner, D. L., O'keefe, S. J. D., Forbes, A., Heinze, H., & Joelsson, B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.007 · Cited by 505
Camilleri, M., Chedid, V., Ford, A. C., Haruma, K., Horowitz, M., Jones, K. L., Low, P. A., Park, S.-Y., Parkman, H. P., & Stanghellini, V. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0038-z · Cited by 411
Eluxadoline for Irritable Bowel Syndrome with Diarrhea
Lembo, A. J., Lacy, B. E., Zuckerman, M. J., Schey, R., Dove, L. S., Andrae, D. A., Davenport, J. M., McIntyre, G., Lopez, R., Turner, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505180 · Cited by 334
Modulation of specific intestinal epithelial progenitors by enteric neurons
Bjerknes, M., & Cheng, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211278098 · Cited by 325
Fundamentals of neurogastroenterology
Wood, J. D., Alpers, D. H., & Andrews, P. L. R. (1999) · Gut · doi:10.1136/gut.45.2008.ii6 · Cited by 311 · cited 1×
“Abnormal excitatory and inhibitory input due to the effect of the autonomic nervous system (sympathetic inhibition of Ach release), neurotransmitters (VIP, NO, substance P, and CGRP), hormones such as corticotropin-releasing factor (CRF), endogenous opioids, and bowel manipulation has been shown to result in various f…”
BackgroundTack, J., Camilleri, M., Chang, L., Chey, W. D., Galligan, J. J., Lacy, B. E., Müller‐Lissner, S., Quigley, E. M. M., Schuurkes, J., De Maeyer, J. H., et al. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05011.x · Cited by 286
Nerves, Reflexes, and the Enteric Nervous System: Pathogenesis of the Irritable Bowel Syndrome
Gershon, M. D. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000156403.37240.30 · Cited by 271
Gastroparesis: a turning point in understanding and treatment
Grover, M., Farrugia, G., & Stanghellini, V. (2019) · Gut · doi:10.1136/gutjnl-2019-318712 · Cited by 256 · cited 2×
“Due to its ability to cross the blood-brain barrier, it also exerts a central antiemetic effect; however, it can cause extrapyramidal side effects as well which is why its use is limited to 12 weeks [135, 142].”
BackgroundA randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
Garsed, K., Chernova, J., Hastings, M., Lam, C., Marciani, L., Singh, G., Henry, A., Hall, I., Whorwell, P., & Spiller, R. (2014) · Gut · doi:10.1136/gutjnl-2013-305989 · Cited by 246
The human enteric nervous system
Schemann, M., & Neunlist, M. (2004) · Neurogastroenterology & Motility · doi:10.1111/j.1743-3150.2004.00476.x · Cited by 213 · cited 1×
“Although the root cause remains elusive, we now know that it is due to the loss of inhibitory neurons of the myenteric plexus resulting in failure of the lower esophageal sphincter (LES) to relax [124, 125].”
BackgroundGlucose sensing and signalling; regulation of intestinal glucose transport
Shirazi-Beechey, S. P., Moran, A. W., Batchelor, D. J., Daly, K., & Al-Rammahi, M. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665111000103 · Cited by 139
Ultrastructural differences between diabetic and idiopathic gastroparesis
Faussone‐Pellegrini, M. S., Grover, M., Pasricha, P. J., Bernard, C. E., Lurken, M. S., Smyrk, T. C., Parkman, H. P., Abell, T. L., Snape, W. J., Hasler, W. L., et al. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01451.x · Cited by 123
Metoclopramide for the treatment of diabetic gastroparesis
Shakhatreh, M., Jehangir, A., Malik, Z., & Parkman, H. P. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1645594 · Cited by 83 · cited 1×
“Metoclopramide, primarily a D2 receptor antagonist with some 5-HT4 receptor agonism, leads to a gastric prokinetic effect by antagonizing synaptic D2 receptors and stimulating 5-HT4 receptors on the enteric neuron [141, 142].”
Background
Cited by
Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis
Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1130689 · Cited by 415
Mechanisms of Chemotherapy-Induced Neurotoxicity
Was, H., Borkowska, A., Bagues, A., Tu, L., Liu, J. Y. H., Lu, Z., Rudd, J. A., Nurgali, K., & Abalo, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.750507 · Cited by 285
Enteric neuropathy in diabetes: Implications for gastrointestinal function
Abdalla, M. M. I. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i22.2852 · Cited by 45
Tomaszek, N., Urbaniak, A. D., Bałdyga, D., Chwesiuk, K., Modzelewski, S., & Waszkiewicz, N. (2025) · Nutrients · doi:10.3390/nu17030486 · Cited by 30
Tao, W., Yu, Y., Tan, D., Huang, X., Huang, J., Lin, C., & Yu, R. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1603442 · Cited by 9
“Novel approaches, including ghrelin receptor agonists, pyloric botulinum toxin injections, and surgical pyloromyotomy, show promise but necessitate thorough evaluation (Fleming et al., 2020; Schol et al., 2021).”
Metadata
- Authors
- Fleming, M. A., Ehsan, L., Moore, S. R., & Levin, D. E.
- Venue
- Gastroenterology Research and Practice
- Publisher
- Wiley
- Published
- 2020-09-08
- Volume
- 2020
- Pages
- 1-13
- ISSN
- 1687-6121 (ISSN-L)
- 1687-630X
- OpenAlex
- W3035623076
- Cited by
- 157
- References
- 21
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.